Diseases

Diseases

Deep White Matter Hyperintensities Associated with Amyloid-Related Imaging Abnormalities in Alzheimer Disease Patients

New research has shed light on the relationship between deep white matter hyperintensities (DWMH) and amyloid-related imaging abnormalities (ARIA) in patients with Alzheimer Disease (AD) treated with lecanemab. Investigators have identified DWMH as a potential imaging biomarker for ARIA risk stratification, suggesting that a higher burden of DWMH, as quantified